Lung cancer patients who are asymptomatic at diagnosis show favorable prognosis: A Korean Lung Cancer Registry Study

Lung Cancer

Volumn 64, Issue 2, 2009, Pages 232-237

  In, Kwang Ho ^a,b   Kwon, Yong Soo ^c   Oh, In Jae ^c   Kim, Kyu Sik ^c   Jung, Maan Hong ^a,d   Lee, Kwan Ho ^a,e   Kim, Sun Young ^a,f   Ryu, Jeong Seon ^a,g   Lee, Sung Yong ^a,b   Jeong, Eun Taik ^a,h   Lee, Sang Yeub ^a,b   Yum, Ho Kee ^a,i   Lee, Chang Geol ^a,j   Kim, Woo Sung ^k   Zo, Jae Ill ^l   Kim, Hojoong ^m   Kim, Young Whan ⁿ   Kim, Se Kyu ^j   Lee, Jae Cheol ^o   Kim, Young Chul ^a,c  

^a The Survey Committee   (South Korea)

^b Korea University   (South Korea)

^c Chonnam National University   (South Korea)

^d Kosin University   (South Korea)

^e Yeungnam University   (South Korea)

^f Chungnam National University   (South Korea)

^g Inha University   (South Korea)

^h Wonkwang University   (South Korea)

ⁱ Inje University   (South Korea)

^j Yonsei University   (South Korea)

^k University of Ulsan   (South Korea)

^l National Cancer Center   (South Korea)

^m Sungkyunkwan University   (South Korea)

ⁿ Seoul National University   (South Korea)

^o Korea Cancer Center Hospital   (South Korea)

more..

Author keywords

Epidemiology; Korea; Lung neoplasms; Registries; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADRENAL METASTASIS; ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; FEMALE; HUMAN; KOREA; LIVER METASTASIS; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SKIN METASTASIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KOREA; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; REGISTRIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 63049110662     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.08.005     Document Type: Article

References (17)

1. Korea National Statistical Office. Death rate statistics of Korea, 2005. Korea National Statistical Office; 2007.
2. Lee C., Kang K.H., Koh Y., Chang J., Chung H.S., Park S.K., et al. Characteristics of lung cancer in Korea, 1997. Lung Cancer 30 (2000) 15-22
3. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710
4. Micke P., Faldum A., Metz T., Beeh K.M., Bittinger F., Hengstler J.G., et al. Staging small cell lung cancer: veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer-what limits limited disease?. Lung Cancer 37 (2002) 271-276
5. Rivera M.P., and Stover D.E. Gender and lung cancer. Clin Chest Med 25 (2004) 391-400
6. Asamura H., Goya T., Koshiishi Y., Sohara Y., Eguchi K., Mori M., et al. A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers. J Thorac Oncol 3 (2008) 46-52
7. Straus G.M., Jemal A., McKenna M.B., Strauss J.A., and Cummings K.M. The epidemic of smoking-related adenocarcinoma of the lung: the role of the tobacco industry and filtered and low-tar cigarettes. J Thorac Oncol 2 (suppl) (2007) S305
8. Straus G.M., Jemal A., McKenna M.B., Strauss J.A., and Cummings K.M. Lung cancer survival in relation to histologic subtypes: an analysis based upon surveillance epidemiology and end results (SEER) data. J Thorac Oncol 2 (suppl) (2007) S345
9. Chang A., Parikh P., Thongprasert S., Tan E.H., Perng R.P., Ganzon D., et al. (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL study. J Thorac Oncol 1 (2006) 847-855
10. Kim K.S., Jeong J.Y., Kim Y.C., Na K.J., Kim Y.H., Ahn S.J., et al. Predictors of the response to gefitinib in refractory non-small cell lung cancer. Clin Cancer Res 11 (2005) 2244-2251
11. Ou S.H., Zell J.A., Ziogas A., and Anton-Culver H. Prognostic factors for survival of stage I nonsmall cell lung cancer patients: a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003. Cancer 110 (2007) 1532-1541
12. Bach P.B., Kelley M.J., Tate R.C., and McCrory D.C. Screening for lung cancer: a review of the current literature. Chest 123 (2003) 72S-82S
13. Henschke C.I., Naidich D.P., Yankelevitz D.F., McGuinness G., McCauley D.I., Smith J.P., et al. Early lung cancer action project: initial findings on repeat screenings. Cancer 92 (2001) 153-159
14. The international early lung cancer action program investigators. International early lung cancer action program. [accessed Jun 2008] available from http://www.ielcap.org/.
15. NCI. National Lung Screening Trial. [accessed Jun 2008] available from http://www.cancer.gov/clinicaltrials/NCI-NLST#StudyIdInfo_CDR0000257938.
16. Henschke C.I., Yankelevitz D.F., Libby D.M., Pasmantier M.W., Smith J.P., and Miettinen O.S. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355 (2006) 1763-1771
17. Black W.C. Overdiagnosis: an underrecognized cause of confusion and harm in cancer screening. J Natl Cancer Inst 92 (2000) 1280-1282